AAG
RVMD icon

Armstrong Advisory Group’s Revolution Medicines RVMD Stock Holding History

Armstrong Advisory Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.74K Hold
52
– – ﹤0.01% 716
2026
Q1 		$5.06K Hold
52
– – ﹤0.01% 781
2025
Q4 		$4.14K Hold
52
– – ﹤0.01% 791
2025
Q3 		$2.43K Hold
52
– – ﹤0.01% 842
2025
Q2 		$1.91K Hold
52
– – ﹤0.01% 844
2025
Q1 		$2.27K Hold
52
– – ﹤0.01% 780
2024
Q4 		$2.27K Hold
52
– – ﹤0.01% 780
2024
Q3 		$2.36K Buy
+52
New +$2.26K ﹤0.01% 724
2024
Q2 		– Sell
-304
Closed -$8.72K – 828
2024
Q1 		$8.72K Hold
304
– – ﹤0.01% 583
2023
Q4 		$8.72K Buy
+304
New +$7.3K ﹤0.01% 583

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Armstrong Advisory Group's RVMD Position: Q2 2026 in Review

Armstrong Advisory Group held its Revolution Medicines (RVMD) position steady in Q2 2026 at 52 shares worth $9.74K. The position accounts for ﹤0.01% of the portfolio, ranked #716.

Armstrong Advisory Group first reported a position in RVMD in Q4 2023 and has held it in 10 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Armstrong Advisory Group held 52 shares of Revolution Medicines worth $9.74K as of Q2 2026.
  • Armstrong Advisory Group left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #716 holding.
  • Armstrong Advisory Group first reported a position in Revolution Medicines in Q4 2023 and has held it in 10 quarters since.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.